{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:04:42Z","timestamp":1769850282000,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4278-7","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T14:03:18Z","timestamp":1563372198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Severe Guillain-Barr\u00e9 syndrome associated with chronic active hepatitis C and mixed cryoglobulinemia: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Alexandre","family":"Chlilek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Jos\u00e9e","family":"Carles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Laureillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9484-0304","authenticated-orcid":false,"given":"Jean-Philippe","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Lefrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Sotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,17]]},"reference":[{"issue":"10","key":"4278_CR1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cmi.2016.07.035","volume":"22","author":"S Lanini","year":"2016","unstructured":"Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: global epidemiology and strategies for control. Clin Microbiol Infect. 2016;22(10):833\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"4278_CR2","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","volume":"61","author":"RH Westbrook","year":"2014","unstructured":"Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61(Suppl 1):S58\u201368.","journal-title":"J Hepatol"},{"issue":"Suppl 5","key":"4278_CR3","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","volume":"46","author":"P Cacoub","year":"2014","unstructured":"Cacoub P, Gragnani L, Comarmond C, Zignego AL. Extrahepatic manifestations of chronic hepatitis C virus infection. Dig Liver Dis. 2014;46(Suppl 5):S165\u201373.","journal-title":"Dig Liver Dis"},{"issue":"12","key":"4278_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4254\/wjh.v8.i12.545","volume":"8","author":"S Mathew","year":"2016","unstructured":"Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, et al. Hepatitis C virus and neurological damage. World J Hepatol. 2016;8(12):545\u201356.","journal-title":"World J Hepatol"},{"issue":"8","key":"4278_CR5","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3748\/wjg.v21.i8.2269","volume":"21","author":"LE Adinolfi","year":"2015","unstructured":"Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, et al. Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol. 2015;21(8):2269\u201380.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"4278_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cld.2017.03.008","volume":"21","author":"S Iriana","year":"2017","unstructured":"Iriana S, Curry MP, Afdhal NH. Neurologic manifestations of hepatitis C virus infection. Clin Liver Dis. 2017;21(3):535\u201342.","journal-title":"Clin Liver Dis"},{"issue":"10045","key":"4278_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016;388(10045):717\u201327.","journal-title":"Lancet."},{"issue":"8","key":"4278_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469\u201382.","journal-title":"Nat Rev Neurol"},{"issue":"10027","key":"4278_CR9","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, et al. Guillain-Barr\u00e9 syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531\u20139.","journal-title":"Lancet."},{"issue":"10","key":"4278_CR10","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1212\/WNL.43.10.2143","volume":"43","author":"N De Klippel","year":"1993","unstructured":"De Klippel N, Hautekeete ML, De Keyser J, Ebinger G. Guillain-Barr\u00e9 syndrome as the presenting manifestation of hepatitis C infection. Neurology. 1993;43(10):2143.","journal-title":"Neurology."},{"issue":"5","key":"4278_CR11","first-page":"551","volume":"19","author":"H Zylberberg","year":"1995","unstructured":"Zylberberg H, Hag\u00e8ge H, Roualdes B, Meyrignac C, Chousterman M. Guillain-Barr\u00e9 syndrome in a patient with chronic active hepatitis C. Gastroenterol Clin Biol. 1995;19(5):551.","journal-title":"Gastroenterol Clin Biol"},{"issue":"1","key":"4278_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1600-0676.1998.tb00126.x","volume":"18","author":"F Lacaille","year":"1998","unstructured":"Lacaille F, Zylberberg H, Hag\u00e8ge H, Rouald\u00e8s B, Meyrignac C, Chousterman M, et al. Hepatitis C associated with Guillain-Barr\u00e9 syndrome. Liver. 1998;18(1):49\u201351.","journal-title":"Liver."},{"issue":"15","key":"4278_CR13","first-page":"739","volume":"30","author":"SA Massengo","year":"2001","unstructured":"Massengo SA, Furby A, Stanescu C, Charasse C, Madigand M. Hepatitis C with cryoglobulinemia associated with Guillain-Barre syndromePresse Med. 2001;30(15):739.","journal-title":"Presse Med"},{"issue":"1","key":"4278_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C. Fokke","year":"2013","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014;137(Pt 1):33\u201343.","journal-title":"Brain"},{"issue":"3","key":"4278_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/brain\/118.3.597","volume":"118","author":"T. W. Ho","year":"1995","unstructured":"Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barr\u00e9 syndrome in northern China. Relationship to campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995;118 ( Pt 3):597\u2013605.","journal-title":"Brain"},{"issue":"10","key":"4278_CR16","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1517\/14656566.2011.564160","volume":"12","author":"N Shahrizaila","year":"2011","unstructured":"Shahrizaila N, Yuki N. The role of immunotherapy in Guillain-Barr\u00e9 syndrome: understanding the mechanism of action. Expert Opin Pharmacother. 2011;12(10):1551\u201360.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"4278_CR17","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.410440512","volume":"44","author":"RD Hadden","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma exchange\/Sandoglobulin Guillain-Barr\u00e9 syndrome trial group. Ann Neurol. 1998;44(5):780\u20138.","journal-title":"Ann Neurol"},{"issue":"8","key":"4278_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.clinph.2012.01.025","volume":"123","author":"A Uncini","year":"2012","unstructured":"Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barr\u00e8 syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123(8):1487\u201395.","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"4278_CR19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.gtc.2015.07.002","volume":"44","author":"Norah J. Shire","year":"2015","unstructured":"Shire NJ, Sherman KE. Epidemiology of hepatitis C virus. A Battle on New Frontiers. Gastroenterol Clin North Am. 2015;44(4):699\u2013716.","journal-title":"Gastroenterology Clinics of North America"},{"issue":"12","key":"4278_CR20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.autrev.2016.09.006","volume":"15","author":"C Ferri","year":"2016","unstructured":"Ferri C, Ramos-Casals M, Zignego AL, Arcaini L, Roccatello D, Antonelli A, et al. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmun Rev. 2016;15(12):1145\u201360.","journal-title":"Autoimmun Rev"},{"key":"4278_CR21","doi-asserted-by":"crossref","unstructured":"Benstead TJ, Chalk CH, Parks NE. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection. Cochrane Database Syst Rev. 2014;(12):CD010404.","DOI":"10.1002\/14651858.CD010404.pub2"},{"issue":"5","key":"4278_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/jnnp.2005.081570","volume":"77","author":"L Santoro","year":"2006","unstructured":"Santoro L, Manganelli F, Briani C, Giannini F, Benedetti L, Vitelli E, et al. Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population. J Neurol Neurosurg Psychiatry. 2006;77(5):626\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"4278_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","volume":"10","author":"M Pietrogrande","year":"2011","unstructured":"Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S, et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev. 2011;10(8):444\u201354.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"4278_CR24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jhep.2017.02.010","volume":"66","author":"M Ramos-Casals","year":"2017","unstructured":"Ramos-Casals M, Al Z, Ferri C, Brito-Zer\u00f3n P, Retamozo S, Casato M, et al. Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. J Hepatol. 2017;66(6):1282\u201399.","journal-title":"J Hepatol"},{"issue":"2","key":"4278_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3748\/wjg.14.318","volume":"14","author":"V Khiani","year":"2008","unstructured":"Khiani V, Kelly T, Shibli A, Jensen D, Mohanty SR. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection. World J Gastroenterol. 2008;14(2):318\u201321.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4278_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4254\/wjh.v2.i4.162","volume":"2","author":"MA Niazi","year":"2010","unstructured":"Niazi MA, Azhar A, Tufail K, Feyssa EL, Penny SF, McGregory M, et al. Guillain-Barre syndrome associated with peginterferon alfa-2a for chronic hepatitis C: a case report. World J Hepatol. 2010;2(4):162\u20136.","journal-title":"World J Hepatol"},{"issue":"4","key":"4278_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/archneur.1987.00520160068017","volume":"44","author":"WN Macleod","year":"1987","unstructured":"Macleod WN. Sporadic non-a, non-B hepatitis and Epstein-Barr hepatitis associated with the Guillain-Barr\u00e9 syndrome. Arch Neurol. 1987;44(4):438\u201342.","journal-title":"Arch Neurol"},{"issue":"3","key":"4278_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jmv.1890210303","volume":"21","author":"Edward Tabor","year":"1987","unstructured":"Tabor E. Guillain-Barr\u00e9 syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B. J Med Virol. 1987;21(3):207\u201316.","journal-title":"Journal of Medical Virology"},{"issue":"10","key":"4278_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1055\/s-2008-1065017","volume":"115","author":"F Gutzler","year":"1990","unstructured":"Gutzler F, Andrassy K, Kommerell B, Krieger D. Guillain-Barr\u00e9 polyneuropathy in Wegener\u2019s granulomatosis with pulmonary-renal syndrome. Dtsch Med Wochenschr. 1990;115(10):372\u20137.","journal-title":"Dtsch Med Wochenschr"},{"issue":"9","key":"4278_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","volume":"10","author":"BR Wakerley","year":"2014","unstructured":"Wakerley BR, Uncini A, Yuki N. GBS classification group, GBS classification group. Guillain-Barr\u00e9 and miller fisher syndromes--new diagnostic classification. Nat Rev Neurol. 2014;10(9):537\u201344.","journal-title":"Nat Rev Neurol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4278-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T23:07:35Z","timestamp":1594854455000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,17]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4278"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4278-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,17]]},"assertion":[{"value":"1 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the editors of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"636"}}